Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06556745 · ClinicalTrials.gov registry record
Pharmacokinetics of Butyrate Tablet BKR-017
A clinical trial of Hypercholesterolemia, sponsored by BioKier.
- Recruiting
- Registry status
- 10
- Enrollment target
- 1
- Study location
NCT06556745: Recruiting study of Hypercholesterolemia, sponsored by BioKier.
NCT06556745 is a study of Hypercholesterolemia that is actively recruiting participants, run by BioKier. The registered enrollment target is 10 participants, below the 817-participant average among 62 other Hypercholesterolemia trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06556745, a study of Hypercholesterolemia, is actively recruiting participants, sponsored by BioKier.
- RECRUITING
- Registry status
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the pharmacokinetic profile and systemic exposure of BKR-017 in individuals on statin therapy after a single dose and at steady state after seven days repeated twice daily dosing.
Primary Outcome
Changes, from pre-dosing levels, in levels of butyrate in plasma after a single dose and after seven days of dosing.
Conditions Studied
Interventions
- DRUG BKR-017
Study Locations (1)
Louisiana
- Pennington Biomedical Research Center - Baton Rouge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-07-16 |
| Est. Completion | 2025-12-30 |
What NCT06556745 shows while recruiting
NCT06556745 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 817-participant average among 62 other Hypercholesterolemia trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Hypercholesterolemia appearing as the primary indexed condition, and to 1 intervention - of which BKR-017 is the first listed.
NCT06556745 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT06556745 about?
NCT06556745 is a clinical study titled "Pharmacokinetics of Butyrate Tablet BKR-017". The purpose of this study is to evaluate the pharmacokinetic profile and systemic exposure of BKR-017 in individuals on statin therapy after a single dose and at steady state after seven days repeated twice daily dosing.
What is the current status of trial NCT06556745?
This trial is currently recruiting. The enrollment target is 10 participants. The study started on 2025-07-16. Estimated completion is 2025-12-30.
What conditions does trial NCT06556745 study?
This clinical trial studies the following conditions: Hypercholesterolemia.
What interventions are being tested in trial NCT06556745?
The interventions under investigation include: BKR-017 (DRUG).
Who is sponsoring clinical trial NCT06556745?
This trial is sponsored by BioKier, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06556745 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypercholesterolemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06556745's enrollment target sits among peer trials
10 62nd of 62 the lowest of 62 other Hypercholesterolemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypercholesterolemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial
RECRUITING · Phase 2
-
Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health
RECRUITING · NA
-
Pharmacogenomic Informed Statin Prescribing
RECRUITING · NA
-
Causes and Natural History of Dyslipidemias
RECRUITING
-
A Tool to Help Patients With Muscle Symptoms After Taking a Statin Medication.
ACTIVE NOT RECRUITING · NA
-
Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI